Enovis (ENOV) Other Non-Current Assets (2010 - 2026)
Enovis' (ENOV) quarterly Other Non-Current Assets came in at $88.9 million in Q3 2026, down 3.81% year-over-year from $92.4 million in Q3 2025, and down 5.4% quarter-over-quarter from $94.0 million in Q2 2026.
Analysis
Enovis (ENOV) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Other Non-Current Assets for 17 consecutive years, with $88.9 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Other Non-Current Assets fell 3.81% year-over-year to $88.9 million in Q3 2026; TTM through Jul 2026 was $88.9 million, a 3.81% decrease from a year earlier, with the FY2025 full-year figure at $93.3 million, up 5.15% from the prior year.
- Other Non-Current Assets was $88.9 million for Q3 2026 at Enovis, down from $94.0 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $374.8 million in Q2 2022 and troughed at $68.0 million in Q3 2022.
- A 5-year average of $104.4 million and a median of $89.0 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 97.83% in 2022 and jumped 39.59% in 2023, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $80.3 million in 2022, then advanced by 12.41% to $90.3 million in 2023, then dropped by 1.64% to $88.8 million in 2024, then gained by 5.15% to $93.3 million in 2025, then fell by 4.77% to $88.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $88.9 million (Q3 2026), $94.0 million (Q2 2026), and $93.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Enovis | 1.08 Bn | 1.06 Bn | 359.25 Mn | 88.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 88.89 Mn |
| Apr 3, 2026 | 93.96 Mn |
| Dec 31, 2025 | 93.35 Mn |
| Oct 3, 2025 | 94.56 Mn |
| Jul 4, 2025 | 92.41 Mn |
| Apr 4, 2025 | 86.74 Mn |
| Dec 31, 2024 | 88.78 Mn |
| Sep 27, 2024 | 90.32 Mn |
| Jun 28, 2024 | 88.65 Mn |
| Mar 29, 2024 | 89.19 Mn |
| Dec 31, 2023 | 90.26 Mn |
| Sep 29, 2023 | 94.94 Mn |
| Jun 30, 2023 | 88.78 Mn |
| Mar 31, 2023 | 87.87 Mn |
| Dec 31, 2022 | 80.29 Mn |
| Sep 30, 2022 | 68.01 Mn |
| Jul 1, 2022 | 88.22 Mn |
| Apr 1, 2022 | 374.82 Mn |
| Dec 31, 2021 | 3.70 Bn |
| Oct 1, 2021 | 352.37 Mn |